Drug Type Chemical drugs |
Synonyms KJ 16002, KJ16002 |
Target |
Action inhibitors |
Mechanism PGES inhibitors(Prostaglandin E synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | South Korea | 31 Oct 2024 |





